Billionaires like Ken Griffin are doling out tons of money to prove that a college degree still matters
Despite questions swirling around colleges and universities, Griffin’s $3 billion donation to Carnegie Mellon University is one of many from billionaires to…
Why the ‘Halloween Indicator’ isn’t working — and what smart investors are doing instead
Followers of ‘sell in May and go away’ have lost out on a stock rally Source：MarketWatch
These bond strategies can help you get a safe 5% return on your cash
With U.S. Treasury yields on the rise, financial planners say they’re seeing a growing interest in bonds, especially among investors looking to secure fixed…
Trump touts economic wins in battleground states — like a $54 billion Alaskan pipeline — as the midterms draw closer
President Donald Trump is spending time this week talking up big jobcreating projects in battleground states. Source：MarketWatch
Former NFL players are nearly four times as likely to die with brain damage. Is it time to boycott football?
New research says the problem is worse than we thought. Source：MarketWatch
The U.S. economy is defying gravity. Here’s all the good news.
Wall Street just got a health check on the U.S. economy — and almost all the news was positive. Source：MarketWatch
Gold is supposed to be a safe haven when inflation surges. So why isn’t it working that way now?
Every investor knows the drill: When markets buckle, buy gold. But in September, that playbook hasn’t worked as expected. Source：MarketWatch
Wall Street may be sleeping on this networking stock tied to Google and OpenAI
A critical bottleneck in data centers is creating a massive runway for networking stocks like Celestica, according to Bernstein. Source：MarketWatch
Saving your retirement could come down to this simple writing exercise
A “retirement policy statement” lays out instructions that you can stick to. Source：MarketWatch
A tough job market is pushing more young Americans to make a big bet: on themselves
There has been a rise in entrepreneurship among young Americans as the entrylevel labor market has become tougher to join. Source：MarketWatch
The 15 worst-performing S&P 500 stocks during a dismal September
The S&P 500 has gained slightly in September, but threequarters of its components have declined. Source：MarketWatch
Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.
The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP1. Source：MarketWatch